Alcohol Related Liver Disease: Epidemiology, Mortality, and Treatment
Nov
13
2023
Grand Ballroom
-
Sheraton Boston Hotel
11:00
AM
- 12:30 PM EST
Speakers
Description
Abstracts
- AMONG YOUNG ADULTS SURVIVING A FIRST PRESENTATION OF ACUTE ALCOHOLIC HEPATITIS, FEMALES ARE AT 50% HIGHER RISK OF PROGRESSION TO CIRRHOSIS AND DECOMPENSATION
- PRE-TREATMENT GUT MICROBIOTA PREDICTS SURVIVAL AFTER FECAL MICROBIOTA TRANSPLANTATION IN SEVERE ALCOHOLIC HEPATITIS
- DECREASED MORTALITY IN PATIENTS WITH SEVERE ALCOHOL-ASSOCIATED HEPATITIS (SAH) TREATED WITH CORTICOSTEROIDS DURING THE COVID PANDEMIC
- SATURATED FAT FAVORABLY ALTERS THE GUT MICROBIOTA AND IMPROVES SURVIVAL IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS: A RANDOMIZED CONTROLLED TRIAL
- SPIRONOLACTONE THERAPY ASSOCIATES WITH REDUCED INCIDENT ALCOHOL-ASSOCIATED LIVER DISEASE IN HIGH RISK PATIENTS: A RETROSPECTIVE COHORT STUDY
- PHOSPHATIDYLETHANOL MONITORING OF POST-TRANSPLANT ALCOHOL CONSUMPTION AMONG ALCOHOL AND NON-ALCOHOL-RELATED LIVER TRANSPLANT RECIPIENTS